Related Experiment Video
Updated: Dec 27, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MicroRNA-30b-5p functions as a metastasis suppressor in colorectal cancer by targeting Rap1b
Mengjing Fan1, Ximei Ma2, Feifan Wang3
1Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Abstract:
Colorectal liver metastasis (CRLM) is the leading cause of death in patients with colorectal cancer (CRC). MiR-30b-5p can function as an oncogene or tumor suppressor in cancers, but its role in CRLM is still unknown. Here, we found that miR-30b-5p overexpression suppressed the invasion, migration, adhesion, and motility of HCT116 and LoVo cells. The expression of EMT (Zeb1, Snail, and vimentin) and adhesion-related proteins (p-paxillin and p-Src) was decreased. We validated Rap1b, a Ras family small GTPase that regulates cell adhesion and mobility, as the direct and functional target of miR-30b-5p. Rap1b overexpression rescued the aggressive characteristics of CRC cells that were inhibited by miR-30b-5p. Rap1b knockdown suppressed invasion and migration and decreased CRC cell-matrix adhesion and spreading, which was consistent with the results of miR-30b-5p overexpression. Further in vivo experiments demonstrated that miR-30b-5p overexpression inhibited CRLM, but Rap1b rescue attenuated the inhibitory effect of miR-30b-5p. In addition, miR-30b-5p was downregulated in CRC specimens, and Rap1b showed a negative correlation with miR-30b-5p expression in primary CRC and LM tissues. These results indicate that miR-30b-5p functions as a metastasis suppressor by targeting Rap1b and may provide a new target for the treatment of CRLM.
Insights
MicroRNA-30b-5p acts as a tumor suppressor in colorectal cancer liver metastasis (CRLM) by inhibiting cell invasion and migration. It targets Rap1b, a protein promoting cell adhesion and mobility, offering a potential therapeutic target for CRLM.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Metastasis Research
Background:
- Colorectal liver metastasis (CRLM) is a primary cause of mortality in colorectal cancer (CRC) patients.
- The precise role of microRNA-30b-5p (miR-30b-5p) in CRLM progression remains largely unelucidated.
- MiR-30b-5p has demonstrated dual roles as an oncogene or tumor suppressor in various cancer types.
Purpose of the Study:
- To investigate the functional role of miR-30b-5p in colorectal cancer liver metastasis.
- To identify the molecular targets of miR-30b-5p involved in CRLM progression.
- To evaluate the therapeutic potential of targeting the miR-30b-5p/Rap1b axis in CRLM.
Main Methods:
- In vitro assays assessing cell invasion, migration, adhesion, and motility in CRC cell lines (HCT116, LoVo).
- Western blot analysis to evaluate the expression of epithelial-mesenchymal transition (EMT) and adhesion-related proteins.
- Validation of Rap1b as a direct target of miR-30b-5p using luciferase reporter assays and rescue experiments.
- In vivo studies using mouse models to assess the effect of miR-30b-5p and Rap1b on CRLM.
- Analysis of miR-30b-5p and Rap1b expression in clinical CRC and liver metastasis (LM) tissues.
Main Results:
- Overexpression of miR-30b-5p significantly suppressed CRC cell invasion, migration, adhesion, and motility.
- MiR-30b-5p downregulated EMT markers (Zeb1, Snail, vimentin) and adhesion-related proteins (p-paxillin, p-Src).
- Rap1b was identified as a direct functional target of miR-30b-5p; its overexpression rescued miR-30b-5p-mediated suppression.
- MiR-30b-5p overexpression inhibited CRLM in vivo, an effect attenuated by Rap1b rescue.
- MiR-30b-5p was downregulated in clinical CRC and LM tissues, inversely correlated with Rap1b expression.
Conclusions:
- MiR-30b-5p functions as a tumor suppressor in colorectal cancer liver metastasis by targeting Rap1b.
- The miR-30b-5p/Rap1b pathway plays a critical role in regulating CRC cell adhesion, migration, and metastasis.
- Targeting miR-30b-5p or its downstream effector Rap1b represents a promising therapeutic strategy for CRLM.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
Abnormal Proliferation
The Ras Gene
Ras is a...

